Status:
COMPLETED
Home-based tDCS for Prevention of Suicidal Ideation
Lead Sponsor:
University of Rochester
Collaborating Sponsors:
Brain & Behavior Research Foundation
Conditions:
Suicidal Ideation
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Risk for suicide is elevated in the period after discharge from hospital among adults with major affective disorder. The primary objective of this study is to investigate the feasibility of delivering...
Eligibility Criteria
Inclusion
- age between 18 and 65 years
- diagnosis of mood or bipolar disorder registered in the electronic hospital medical record
- history of suicidal ideation and/or suicidal behavior at the time of admission registered in the electronic hospital medical record
- absent of suicidal ideation at the time of enrollment (defined as questions 1 and 2 of the C-SSRS answered "no")
- ability and willingness to provide information and permission to contact at least one person in the case of a need to contact them to promote subject safety or inability to reach the subject for follow-up
- a living situation with access to a private space suitable for the administration of the RS-tDCS sessions in the next three weeks
- agree to use a medically acceptable form of birth control while receiving the treatment if you are an individual able to become pregnant
- living in Monroe County region, as this is the area covered by the Mobile Crisis Team, a URMC psychiatric emergency team serving anyone within Monroe County
- device or computer with internet access for a URMC-approved remote RS-tDCS supervision
- ability to manage proper use of the device in a practice session
Exclusion
- acute psychiatric instability or substance abuse (e.g., psychotic symptoms, alcohol misuse in the previous three months, use of any illicit drugs in the previous three months)
- unstable medical condition with reduction of functional capacity
- history of epilepsy or seizures in the last year
- history of neurodegenerative diseases registered in the electronic hospital medical record
- presence of or implanted any ferromagnetic metal in the head or the neck
- pregnant or breastfeeding or willingness to become pregnant in the next month
- history of head trauma (e.g., head injury, brain injury) or neurosurgery
- history of skin disorder or sensitive skin area near stimulation locations
- the presence of pacemaker
- current treatment with electroconvulsive therapy or transcranial magnetic stimulation
Key Trial Info
Start Date :
September 21 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 11 2024
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT05280756
Start Date
September 21 2023
End Date
June 11 2024
Last Update
May 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rochester
Rochester, New York, United States, 14642